Single-dose Intravenous Ondansetron in Children with Gastroenteritis: A Randomized Controlled Trial
Indian Pediatr
;
2019 Jun; 56(6): 468-471
Artigo
| IMSEAR
| ID: sea-199224
ABSTRACT
Objective:
To evaluate the efficacy of ondansetron for thetreatment of vomiting and thus reducing the need for intravenous(IV) rehydration in children with gastroenteritis.Design:
Double-blind, placebo-controlled, randomized trial.Setting:
Pediatric ward of An Giang General Hospital, SouthVietnam, between December 2013 and June 2014.Participants:
61 inpatient children (age 11-60 mo) suffering fromgastroenteritis with vomiting. Exclusion criteria were underlyingchronic conditions, immunodeficiency, malnutrition or history ofallergy to ondansetron.Intervention Single bolus of IV ondansetron at a dose of 0.2 mg/kg or placebo.Outcomemeasures:
Proportion of patients who needed IVrehydration, proportion of patients with cessation of vomiting,amount of oral rehydration solution intake, duration of diarrheaand the length of hospital stay.Results:
After drug administration, 22 (73%) of the 30 patients inthe ondansetron group had complete cessation of vomitingcompared with 7 (23%) of the 31 patients in the placebo group(RR 0.32; 95% CI 0.16 to 0.63, P<0.001). 3 (10%) patients inthe ondansetron group required IV rehydration as comparedwith 12 (39%) in the placebo group (RR 0.51; 95% CI 0.33 to0.79, P=0.009). The median amount of oral rehydration solutionintake in 24 hours was significantly greater in the ondansetrongroup (450 mL vs 350 mL, P=0.019).The duration of diarrheaand the length of hospital stay were not different between the twogroups.Conclusion:
In hospitalized children having gastro-enteritisassociated with emesis, ondansetron is effective in the cessationof episodes of vomiting and in lowering the rates of IV rehydration,without reducing the duration of diarrhea and hospital stay
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Tipo de estudo:
Ensaio Clínico Controlado
Revista:
Indian Pediatr
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS